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Abstract
Background: The presence of β-lactamases in Y. enterocolitica has been reported to vary with
serovars, biovars and geographical origin of the isolates. An understanding of the β-lactamases in
other related species is important for an overall perception of antibiotic resistance in yersiniae. The
objective of this work was to study the characteristics of β-lactamases and their genes in strains of
Y. intermedia and Y. frederiksenii, isolated from clinical and non-clinical sources in India.
Results: The enzymes, Bla-A (a constitutive class A penicillinase) and Bla-B (an inducible class C
cephalosporinase) were found to be present in all the clinical and non-clinical strains of Y. intermedia
and Y. frederiksenii by double disc diffusion method. The results showed differential expression of
Bla-A as indicated by presence/absence of synergy whereas expression of Bla-B was quite
consistent. The presence of these enzymes was also reflected in the high minimum inhibitory
concentrations, MIC50 (126–1024 mg/L) and MIC90 (256–1024 mg/L) of β-lactam antibiotics against
these species. Restriction fragment length polymorphism (RFLP) revealed heterogeneity in both
blaA and blaB genes of Y. intermedia and Y. frederiksenii. The blaA gene of Y. intermedia shared
significant sequence identity (87–96%) with blaA of Y. enterocolitica biovars 1A, 1B and 4. The
sequence identity of blaA of Y. frederiksenii with these biovars was 77–79%. The sequence identity
of blaB gene of Y. intermedia and Y. frederiksenii was more (85%) with that of Y. enterocolitica biovars
1A, 1B and 2 compared to other species viz., Y. bercovieri, Y. aldovae and Y. ruckeri. Isoelectric
focusing data further revealed that both Y. intermedia and Y. frederiksenii produced Bla-A (pI 8.7) and
"Bla-B like" (pI 5.5–7.1) enzymes.
Conclusion: Both Y. intermedia and Y. frederiksenii showed presence of blaA and blaB genes and
unequivocal expression of the two β-lactamases. Limited heterogeneity was detected in blaA and
blaB genes as judged by PCR-RFLP. Phylogenetic relationships showed that the two species shared
a high degree of identity in their bla genes. This is the first study reporting characteristics of β-
lactamases and their genes in strains of Y. intermedia and Y. frederiksenii isolated from Asian region.
Background
The genus Yersinia, a highly heterogenous organism is cur-
rently represented by eleven known species [1]. Y. pestis, Y.
pseudotuberculosis and Y. enterocolitica are very well docu-
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mented human pathogens. Y. pestis is the etiologic agent
of plague (black death) while the other two are known to
cause a variety of gastrointestinal syndromes [2]. The
remaining eight species namely Y. intermedia, Y. frederikse-
nii, Y. kristensenii, Y. bercovieri, Y. mollaretii, Y. aldovae, Y.
rohdei and Y. ruckeri have generally been termed as "Y.
enterocolitica-like" species though each is a distinct species.
Although most commonly isolated from sources like fresh
water and food, these have only been infrequently recov-
ered from human clinical specimens [1]. But, some of
these, especially Y. intermedia and Y. frederiksenii may con-
stitute as much as 18–32% of all Yersinia isolated from
stools of diarrheic patients [3]. However, not much infor-
mation is available about these, and Sulakvelidze termed
them as the ignored species [1]. Nevertheless, Y. interme-
dia [4], Y. frederiksenii [5], Y. bercovieri [6] and Y. kristense-
nii [7] have been strongly implicated in cases of diarrhoea.
It is therefore important to know more about these species
to understand their public health significance.
The production of β-lactamases is an important mecha-
nism of resistance to β-lactam antibiotics. In Y. enterocol-
itica, the distribution and production of β-lactamases
namely Bla-A (a constitutive class A enzyme) and Bla-B
(an inducible class C cephalosporinase or AmpC) has
been studied widely and reported to vary with biovars and
geographical origin of the strains [8-11]. However, not
much is known about the β-lactamases of other important
species like Y. intermedia, Y. frederiksenii and Y. kristensenii.
Recently, Y. intermedia, Y. frederiksenii, and some strains of
Y. kristensenii and Y. rohdei were reported to produce two
β-lactamases [12,13]. On the other hand, Y. bercovieri and
Y. mollaretii have been reported to produce only AmpC β-
lactamase, while Y. aldovae and Y. ruckeri showed either
low levels of AmpC or no expression of β-lactamases at all
[14]. This information has been inferred from MIC data of
β-lactam antibiotics. Schiefer et al [15] recently character-
ized β-lactamases of Y. frederiksenii, Y. bercovieri, Y. aldovae
and Y. ruckeri and reported that except for Y. frederiksenii,
all expressed only an AmpC β-lactamase. Mammeri et al
[16] cloned and sequenced the complete ampC gene of Y.
ruckeri and found that it shared low level of identity with
the known chromosomal and plasmid AmpC enzymes of
closely related members, viz., Enterobacter cloacae, E. aero-
genes and Citrobacter freundii. Much of these data however
pertains to strains isolated in Europe. It would be worth-
while to study the β-lactamases and bla genes of strains
isolated from other parts of the world to understand the
global drug resistance of yersiniae. No data is available on
β-lactamases of "Y. enterocolitica-like" species isolated
from Asian region. Therefore, the objective of this work
was to detect and characterize the β-lactamases and bla
genes of Y. intermedia and Y. frederiksenii isolated from
clinical and non-clinical sources in India.
Results and discussion
Phenotypic detection of Bla-A and Bla-B enzymes
All the clinical and non-clinical isolates of Y. intermedia
and Y. frederiksenii showed presence of Bla-A as indicated
by the appearance of a small zone of inhibition of 2–8
mm radii (10–22 mm diameter) around ticarcillin 75 μg
disc (Table 1). However, synergy, the appearance of a
characteristic additional zone of inhibition between ticar-
cillin and the adjacent clavulanate disc, was detected in
only 26% (9/34) of the isolates of Y. intermedia and one
isolate of Y. frederiksenii. In an earlier study, similar obser-
vations regarding synergy were made for strains of Y. ente-
rocolitica biovar 1A [8]. In the present study, Bla-B, the
inducible cephalosporinase, was detected unequivocally
based on the characteristic flattening of inhibition zone
around cefotaxime disc adjacent to the imipenem disc in
all the strains (Table 1). Tzelepi et al [17] also reported
detection of a broad spectrum penicillinase (Bla-A) and
an inducible cephalosporinase (Bla-B) in all the thirty
aquatic isolates of Y. intermedia. Our study extends this
information further to indicate that Bla-A was also present
in Y. intermedia isolated from clinical and non-clinical
(pig/wastewater) sources. In addition, the present study
also showed unequivocal presence of Bla-A and Bla-B in
strains of Y. frederiksenii, which was inferred earlier on the
basis of MIC data only [12,13].
For Bla-A, a larger zone of inhibition (4–8 mm) around
ticarcillin disc (75 μg) was observed for wastewater iso-
lates of Y. intermedia compared to that of clinical (1.5–2.0
mm) isolates. The zone of inhibition (1.5–8 mm) around
Y. intermedia was nevertheless larger compared to that
around the strains of Y. frederiksenii (1.5–3.6 mm). Also,
synergy i.e., appearance of an additional zone of inhibi-
tion around ticarcillin disc, was observed in the clinical
isolates only. As these phenomena are highly dependent
on the degree of the expression of enzyme, these observa-
tions suggested differential expression of Bla-A as reported
earlier for strains of Y. enterocolitica biovar 1A [8].
Minimum Inhibitory Concentration (MIC)
All the strains were resistant to penicillins and cepha-
losporins tested. When analyzed separately, no difference
was observed in the antibiotic susceptibilities of Y. inter-
media and Y. frederiksenii. Thus, the combined results are
shown in Table 2. The MIC50 of amoxicillin was 512 mg/
L for the clinical and 1024 mg/L for the non-clinical
strains, whereas MIC90 was 1024 mg/L and 2048 mg/L,
respectively. For co-amoxiclav, the MIC50 ranged from
128–256 mg/L and MIC90 was 256–512 mg/L for both
clinical and non-clinical strains. The strains were equally
resistant to cephalosporins. Amongst these, minimum
resistance (MIC50 32–64 mg/L and MIC90 128 mg/L) was
seen against cefotaxime for strains of Y. intermedia and Y.
frederiksenii. For ceftazidime, the MIC50 and MIC90 wereBMC Microbiology 2007, 7:25 http://www.biomedcentral.com/1471-2180/7/25
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512 mg/L and 1024 mg/L respectively, and for cefepime,
the values ranged from 256–1024 mg/L. Contrary to
these, relatively lower MICs of penicillins and cepha-
losporins have been reported for Y. intermedia and Y. fred-
eriksenii isolated in other parts of the world [13,17,18].
This may be due to difference in the sources from which
organisms were isolated or their geographical origin.
Interestingly, Tzelepi et al [17] found that the strains of Y.
intermedia isolated in Europe were sensitive to both cefo-
taxime and ceftazidime. The antibiotic resistance data of
strains of Y. intermedia and Y. frederiksenii was in accord-
ance with the preliminary reports from our laboratory ear-
lier [19].
PCR amplification and restriction digestion of blaA gene
The β-lactamase genes namely the blaA  and  blaB  were
detected by PCR amplification and found to be present in
all strains of Y. intermedia and Y. frederiksenii.
Initially, an attempt was made to amplify blaA using pub-
lished primers (A9-f and A10-r) of Y. enterocolitica biovar
1A [20]. However, though some of the strains of Y. inter-
media yielded expected amplicon, none of the Y. frederik-
senii strains gave any amplicon. This may be attributed to
differences in the gene sequences of blaA of Y. intermedia
and Y. frederiksenii compared to that of Y. enterocolitica
biovar 1A. Thus, to amplify blaA of Y. intermedia and Y. fre-
deriksenii, new internal primers (A7-f and A8-r) were
designed. When these primers were used for amplification
of blaA, the expected 450 bp amplicon was obtained for
all the forty-nine strains of Y. intermedia and Y. frederikse-
nii.
Restriction digestion of blaA with NciI revealed that a sin-
gle site for NciI was present in blaA of only a few strains of
Y. intermedia and Y. frederiksenii as either an uncut DNA or
two fragments of 350 bp and 100 bp were obtained (Fig.
1). However, restriction with HaeIII gave three types of
patterns having molecular weights 210, 190 and 60 bp
(pattern I), 210, 190 and 55 bp (pattern II), and 350 and
100 bp (pattern III), for both Y. intermedia and Y. frederik-
senii. The phylogenetic relationship and genetic heteroge-
neity in blaA was studied by constructing a concatenated
dendrogram (Fig. 2) of the NciI and HaeIII restriction pro-
files. The strains of Y. intermedia grouped into three major
clusters: A, B and C. Cluster A was formed by three waste-
water isolates (T/Y/65, R/Y/59 and O/Y/60, all of serovar
O:40). Cluster B was most heterogenous comprising clin-
ical, wastewater and pig throat isolates while the cluster C
was represented predominantly by pig throat isolates (Fig.
2a). The clusters B and C were divided further into two
subclusters each. The blaA-RFLP grouped strains of Y. fre-
deriksenii  into two major clusters – A and B (Fig. 2b).
Except for one, all the strains of clinical origin belonged to
cluster B. As observed for Y. intermedia, the strains of Y. fre-
deriksenii isolated from pig throat also clustered separately
into subgroup BII (Fig. 2b). Earlier, work from our labora-
tory reported that some clinical and non-clinical strains of
Y. enterocolitica biovar 1A formed separate clusters based
on blaA-RFLP [20].
Table 2: Susceptibility of Y. intermedia and Y. frederiksenii to selected antibiotics
Source (n) MIC50(mg/L) MIC90(mg/L)
AMX AMC CTX CAZ FEP AMX AMC CTX CAZ FEP
Clinical (10) 512 128 64 512 512 1024 256 128 1024 1024
Non-clinical (39)a 1024 256 32 512 256 2048 512 128 1024 512
n Number of strains; AMX, Amoxicillin; AMC, Co-amoxiclav; CTX, Cefotaxime; CAZ, Ceftazidime; FEP, Cefepime
aWatsewater (8 strains) and Pig throat (31 strains)
Table 1: Detection of β-lactamases Bla-A and Bla-B in Y. intermedia and Y. frederiksenii isolated from India
Species Source (n) Detection of Bla-A Detection of Bla-B
Number positivea (%) Synergyb (%) Number positivec (%)
Y. intermedia Clinical (4) 4 (100) - 4 (100)
Wastewater (8) 8 (100) 4 (50) 8 (100)
Pig throat (22) 22 (100) 5 (22.7) 22 (100)
Y. frederiksenii Clinical (6) 6 (100) - 6 (100)
Pig throat (9) 9 (100) 1 (11.1) 9 (100)
n number of strains
anumber of strains with annular radii between 2–8 mm (diameter 10–22 mm) of the zone of inhibition around ticarcillin disc
bSynergy – additional zone of inhibition between ticarcillin and co-amoxiclav discs
cnumber of strains that showed characteristic flattening of the zone of inhibition around cefotaxime disc.BMC Microbiology 2007, 7:25 http://www.biomedcentral.com/1471-2180/7/25
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Several reports indicate that genetic background of anti-
biotic resistance genes influence antibiotic susceptibility
profiles [21,22]. However, no such unequivocal relation-
ship between blaA-RFLP type and antibiotic susceptibility
was observed in this study. The present work however,
clearly revealed heterogeneity in blaA gene of Y. intermedia
and Y. frederiksenii, which may account for differential
expression of Bla-A enzyme as seen in double disc diffu-
sion method. Nevertheless, the heterogeneity was only
limited as observed earlier for blaA gene of Y. enterocolitica
biovar 1A strains [20]. In Moraxella catarrhalis, the two
class A β-lactamase genes namely BRO-1 and BRO-2, have
been reported to give different restriction profiles with
BcgI [23,24].
PCR amplification and restriction digestion of blaB gene
PCR amplification of blaB gene resulted in 850 bp product
for all the forty-nine strains of Y. intermedia and Y. freder-
iksenii. The restriction digestion of blaB of Y. intermedia
and Y. frederiksenii with HaeIII gave two types of patterns
i.e., 700 bp and 100 bp, and 600 bp and 120 bp (Fig. 1).
With RsaI, except for the three wastewater isolates of Y.
intermedia  (T/Y/65, R/Y/59 and O/Y/60), all strains of
both the species showed identical pattern, with fragment
sizes of 650 bp and 195 bp. The concatenated dendro-
gram of blaB-RFLP grouped the strains of Y. intermedia
into three major clusters: A, B and C. As with blaA, except
for the three wastewater isolates (T/Y/65, R/Y/59 and O/
Y/60), all the clinical and majority of the wastewater iso-
lates grouped together in cluster B, whereas group C con-
sisted exclusively of pig throat isolates (84%) (Fig. 3a).
Cluster analysis of restriction profiles of Y. frederiksenii
revealed that except for two, all clinical and pig throat
strains grouped together in one major cluster (Fig. 3b). In
a previous study, when the same restriction enzymes
(HaeIII and RsaI) were used, no heterogeneity was dis-
cerned in blaB gene of Y. enterocolitica biovar 1A [20]. This
suggested that blaB gene of Y. intermedia and Y. frederikse-
nii was more heterogenous compared to that of Y. entero-
colitica.
Sequencing of bla genes
The  blaA  gene sequence of Y. intermedia showed high
degree of identity with Y. enterocolitica biovar 1A (96.8%)
[20], Y. enterocolitica 8081 biovar 1B (90%) and Y. entero-
colitica Y-56 biovar 4 (87.7%) [25]. The identity of blaA of
Y. frederiksenii with that of the above-mentioned organ-
isms was however found to be 77%, 79.5% and 79.8%
respectively, suggesting a distinct lineage of Y. frederiksenii.
The sequence identity of blaA gene of Y. intermedia and Y.
frederiksenii with other members of the family Enterobacte-
riaceae namely Klebsiella oxytoca and Citrobacter koseri was
comparatively very low and ranged from 48–50% for Y.
intermedia and 62–63% for Y. frederiksenii. Furthermore,
identity of blaA of Y. intermedia and Y. frederiksenii with
Burkholderia cepacia, a non-enterobacterial species was
47.7% and 60%, respectively.
The deduced amino acid sequences of Bla-A of Y. interme-
dia and Y. frederiksenii were analyzed to check similarity in
β-lactamases at protein level (Fig. 4). The SXXK tetrad,
characteristic of β-lactamases possessing a serine active
site, was present at position 70–73 [26]. In addition, two
structural motifs characteristic of class A β-lactamases,
were also found to be present in Bla-A of Y. intermedia and
Y. frederiksenii: SDN at position 130–132 and KTG at posi-
tion 234–236 along with the motif responsible for omega
(Ω) loop formation, i.e., 166(EPDLN)170. The amino acid
sequence alignment revealed high degree of identity (87–
94%) of Bla-A of Y. intermedia and Y. frederiksenii with that
of Y. enterocolitica biovars 1A, 1B and 4. The percent iden-
tity of Bla-A of Y. frederiksenii with K. oxytoca and C. koseri
was found to be higher (69–71%) compared to that of Y.
intermedia  (49–53%). Overall, the data suggested that
class A β-lactamase of Y. intermedia shared high identity
with Y. enterocolitica, and that of Y. frederiksenii with other
members of the family Enterobacteriaceae and B. cepacia.
This seems to reiterate the distinct lineage of Y. frederikse-
nii as suggested by other investigators based on 16S rDNA
and gyrase B genes sequence analyses [27].
The nucleotide sequences of blaB of Y. intermedia and Y.
frederiksenii were found to have 85% identity with that of
Types of restriction profiles of blaA with NciI (Lanes 1–2) and  HaeIII (Lanes 3–5), and blaB with HaeIII (Lanes 6–7) and RsaI  (Lanes 8–9) Figure 1
Types of restriction profiles of blaA with NciI (Lanes 
1–2) and HaeIII (Lanes 3–5), and blaB with HaeIII 
(Lanes 6–7) and RsaI (Lanes 8–9). PCR amplification and 
restriction analysis were carried out for 49 strains of Y. inter-
media and Y. frederiksenii. M, molecular weight DNA marker 
(100 bp DNA ladder)BMC Microbiology 2007, 7:25 http://www.biomedcentral.com/1471-2180/7/25
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Phylogenetic analysis of blaA gene of (A)Y. intermedia and (B) Y. frederiksenii Figure 2
Phylogenetic analysis of blaA gene of (A)Y. intermedia and (B) Y. frederiksenii. NAG, non-agglutinable; -, Not deter-
mined; St, Serotype; Bt, BiotypeBMC Microbiology 2007, 7:25 http://www.biomedcentral.com/1471-2180/7/25
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Y. enterocolitica biovar 1A, Y. enterocolitica 8081 biovar 1B
and Y. enterocolitica IP97 biovar 2, and 77% with Y. bercov-
ieri. But it was only 50–55% with Y. aldovae and Y. ruckeri.
The deduced amino acid sequence similarity of Bla-B of Y.
intermedia and Y. frederiksenii with Y. enterocolitica biovars
1A, 1B and 2 ranged from 89–92%. The comparison of
these sequences with that of other "Y. enterocolitica-like"
species such as Y. bercovieri,  Y. aldovae and  Y. ruckeri
showed percent identity of 80%, 53% and 49% respec-
tively. Thus, the phylogenetic relationships as discerned
by multilocus enzyme electrophoresis [28,29] were reiter-
ated in antibiotic resistance genes, both at the nucleotide
and the protein level. The deduced amino acid sequence
of Bla-B also revealed presence of the three characteristic
motifs viz., 64SXXS67, 150YAN152 and 314KTG316 (Fig. 5).
Molecular weight determination of Bla-A and Bla-B
Molecular weight determination on SDS-PAGE showed
two distinct bands of 37 kDa and 29 kDa for all strains of
Y. intermedia and Y. frederiksenii. The band at 37 kDa was
characteristic of Bla-A enzyme, as the molecular weight of
most class A β-lactamases from other organisms namely Y.
enterocolitica [20], Burkholderia pseudomallei [30] and Citro-
bacter sedlakii [31] has been reported to vary between 29–
35 kDa. The identity of this band was also confirmed by
specific inhibition with clavulanic acid. The band at 29
kDa corresponded to Bla-B (AmpC) as indicated by its
specific inhibition with aztreonam. The molecular weight
of inducible cephalosporinases or AmpC of other species
namely Y. enterocolitica [32], Y. aldovae, Y. bercovieri, Y.
ruckeri  and Y. frederiksenii [15], and Serratia marcescens
[33], has however been reported to be in the range of 34–
40 kDa. The 29 kDa as found in the present study was sim-
ilar to 29 kDa AmpC of Vibrio fischeri [34] and Y. enteroco-
litica biovar 1A [20]. Since most studies cited above used
SDS-PAGE to determine the molecular weight, the differ-
ences cannot be attributed to methodology.
Isoelectric focusing analysis of Bla-A and Bla-B
Isoelectric focusing of β-lactamases of fifteen strains (8 Y.
intermedia and 7 Y. frederiksenii) revealed a single band in
the alkaline region of the gel at pI 8.7 (Table 3) that corre-
sponded to Bla-A as indicated by its inhibition by clavu-
lanic acid. Tzelepi et al [35] reported that Bla-A of Y.
intermedia focused at pIs 9.0–9.5. The Bla-A of Y. enteroco-
litica with pI 8.7 has been reported by several investigators
[20,36,37].
The inducible cephalosporinase or AmpC β-lactamase
focused as multiple bands in the acidic region of the gel at
various pI values. The identity of these bands was con-
firmed both by induction with imipenem that made the
bands more prominent, and also by specific inhibition
with aztreonam. Two major bands in acidic region of the
gel at pI 6.5 and 6.8 were observed for the clinical strains
of Y. intermedia. The AmpC of non-clinical strains of Y.
intermedia focused at pI ranging from 5.5 to 7.1 (Table 3).
Two additional bands (pI 7.8 and 8.0) were observed in
the pig throat strains. The only report on Bla-B (AmpC) of
Y. intermedia reported pI to be between 5.5 to 6.1 [35]. The
Bla-B of all the strains of Y. frederiksenii also appeared as
multiple bands at pI 6.0, 6.8 and 8.0. The strains of Y.
enterocolitica, for which most information is available in
literature [36,37], produced Bla-B with pI 5.3–5.7 except
biovar 1A strains, the Bla-B of which focused at pI 6.8 and
7.1. Consequently, the Bla-B of biovar 1A strains has been
termed as "Bla-B like" [11]. The present study indicated
that, like biovar 1A strains, Y. intermedia and Y. frederikse-
nii too produced "Bla-B like" enzyme.
Nucleotide sequence accession numbers
The nucleotide sequence data of blaA and blaB has been
submitted to NCBI GenBank under accession numbers
[GenBank: DQ424965 and GenBank: DQ656113], and
[GenBank: DQ424967 and GenBank: DQ424968] respec-
tively.
Conclusion
The two β-lactamases namely Bla-A and Bla-B were
detected in all clinical and non-clinical strains of Y. inter-
media and Y. frederiksenii isolated from India. Differential
expression of Bla-A but not Bla-B was observed by double
disc diffusion method. Both Y. intermedia and Y. frederik-
senii were highly resistant to β-lactam antibiotics. PCR-
RFLP revealed that blaA and blaB genes of both Y. interme-
dia and Y. frederiksenii were heterogeneous. Phylogenetic
relationships also showed that the two species shared
high degree of identity in their bla genes. Isoelectric focus-
ing data revealed that both Y. intermedia and Y. frederikse-
nii produced Bla-A and "Bla-B like" enzymes. This is the
first study in which β-lactamases (Bla-A and Bla-B) and β-
lactamase genes (blaA and blaB) of Y. intermedia and Y. fre-
deriksenii isolated from Asian region have been investi-
gated.
Methods
Bacterial strains
Thirty four strains of Y. intermedia and fifteen of Y. freder-
iksenii  isolated in India [38,39] from different sources
namely diarrheic human subjects (10 strains), pig throat
(31 strains) and wastewater (8 strains) were examined.
The strains were authenticated by, and have been depos-
ited with the Yersinia National Reference Laboratory and
WHO Collaborating Centre at Institut Pasteur (Paris),
France. The details of the strains are given in Table 4.
Antibiotics and chemicals
Mueller-Hinton agar (MHA), tryptone glucose yeast
extract (TGYE) agar, tryptone soya broth (TSB) and anti-
biotic discs, namely ticarcillin 75 μg and imipenem 10 μgBMC Microbiology 2007, 7:25 http://www.biomedcentral.com/1471-2180/7/25
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Phylogenetic analysis of blaB gene of (A)Y. intermedia and (B) Y. frederiksenii Figure 3
Phylogenetic analysis of blaB gene of (A)Y. intermedia and (B) Y. frederiksenii. NAG, non-agglutinable; -, Not deter-
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were obtained from HiMedia, Mumbai (India). Co-amox-
yclav 3 μg (containing 2 μg amoxicillin and 1 μg clavu-
lanate) and cefotaxime 5 μg discs, and nitrocefin were
purchased from Oxoid (Basingstoke, UK). Amoxicillin
and ceftazidime were purchased from HiMedia. Cefotax-
ime, co-amoxiclav (augmentin) and cefepime (meg-
apime) were from Nicholas Piramal India Ltd.,
GlaxoSmithKline Pharmaceuticals Ltd and Alkem Labora-
tories Ltd, Mumbai (India) respectively.
Phenotypic detection of Bla-A and Bla-B enzymes
Detection of the enzymes Bla-A and Bla-B was carried out
by double disc diffusion tests as described previously by
Pham et al [9] and Pham and Bell [40] respectively.
Briefly, culture grown overnight on TGYE agar was used to
prepare a suspension of the test organism containing 107
CFU/ml (A600 = 0.1). MHA plates were inoculated by
flooding these with 2.5 ml of this suspension. The excess
was removed and plates were allowed to dry. For detec-
tion of Bla-A, ticarcillin 75 μg and co-amoxiclav 3 μg discs
were placed on the plate, with adjacent edges 22 mm
apart. The plates were incubated at 28°C for 20 hours.
After incubation, the radii and diameter of the zone of
inhibition around ticarcillin disc were recorded. The
plates were also observed for presence of synergy (an addi-
tional zone of inhibition) between ticarcillin and co-
amoxiclav discs. For detection of enzyme Bla-B, cefotax-
ime 5 μg and imipenem 10 μg discs were placed similarly
on MHA plate and incubated. The characteristic flattening
of the zone of inhibition around cefotaxime disc adjacent
to the imipenem disc was interpreted as presence of Bla-B.
Minimum Inhibitory Concentrations (MIC)
The MICs of five selected antibiotics namely amoxicillin,
co-amoxiclav, cefotaxime, ceftazidime and cefepime were
determined in Mueller-Hinton broth by microbroth dilu-
tion technique using the methodology described by the
Working Party of the British Society for Antibacterial
Chemotherapy [41].
PCR amplification of blaA and blaB genes
Total genomic DNA from each strain was extracted by
DNA extraction kit (Qiagen, Germany) as per the manu-
facturer's instructions. PCR amplification of blaA gene
from all strains of Y. intermedia and Y. frederiksenii was
performed using the primers, A7-f (5' TATGCCCCGAT-
CACGCGTAAAAATCT 3') and A8-r (5' CAAAGTACCG-
CAATATCATTGGTGGT 3'). These were designed by
aligning sequences of blaA genes of Y. enterocolitica biovar
1A [20], Y. enterocolitica 8081 biovar 1B [42] and Y. ente-
rocolitica Y-56 biovar 4 [25] and the expected amplicon
size was 450 bp. The blaB gene was amplified using pub-
lished primers blaB5 (5'CCCACTTTATACCTT-
GGCACAAA 3') and blaB3
Amino acid sequence alignment of class A β-lactamase (Bla-A) of Y. intermedia (strain C-702) with its nearest β-lactamase neigh- bors Figure 4
Amino acid sequence alignment of class A β-lactamase (Bla-A) of Y. intermedia (strain C-702) with its nearest 
β-lactamase neighbors. The partial sequence of Bla-A of Y. frederiksenii was not included in alignment analysis because the 
deduced amino acid sequence was of 121 residues only. Asterisks indicate identical amino acids. The conserved motifs 
(70SXXK73, 130SDN132 and 234KTG236) typical of class A β-lactamases are underlined and in boldface. The motif 166EXXLN170 
responsible for omega-loop formation is in boldface and italics. Arrows indicate the putative omega (Ω) loop region. The Gen-
Bank accession numbers of the β-lactamases are as follows: Y.intem_702 (Y. intermedia, ABD84039, present study),Y.ent_1A 
(AAX55643, Y. enterocolitica biovar 1A), Y.ent_1B (Y. enterocolitica 8081 biovar 1B), Y.ent_4 (CAA40357, Y. enterocolitica, Y-56 
biovar 4), K.oxy, (AAA25084, K. oxytoca) and C.kos (CAA44485, C. koseri).
Y.intem_702       ----------LLAGITLPLVNFSLPTWAAGIPGSLDKQLAALEHSANGRLGIAMINTGNGTKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH 110
70
Y.ent_1A          MKHSSLRRALLLAGITLPLVNFSLPTWAAAIPGSLDKQLAALEHSANGRLGIAMINTGNGTKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH 120
Y.ent_1B          MKHSSLRRSLLLAGITLPLVNFALPTWAAAIPGSLDKQLAALEHSANGRLGIAMINSGAGTKILYRGAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAC 120 
Y.ent_4           MKHSSLRRSLLLAGITLPLVSFALPAWANALPASVDKQLAELERNANGRLGVAMINTGNGTKILYRAAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH 120 
K.oxy             MLKSSWRKTALMAAAAVPLLLASGSLWASADAI--QQKLADLEKRSGGRLGVALINTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQS 118 
C.kos             KTRSSDGTYCRRARFLYCQFTAFGSHAGGAHTG--PTKAGSIRKKSGGRLGVALINTADRSQILYRGDERFAMCSTFKTMVAAAVLKQSETQHDILQQKMVIKKADLTNWNPVTEKYVDK 118 
                                          .  . . .  :  : . :.: :.****:*:**:.  :: ***. .**.:*** * * ***** **::: :::::::  :::** : *:*.* :
Y.intem_702       GMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPNDPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKT 230 
Y.ent_1A          GMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPNDPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKT 240 
Y.ent_1B          GMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPNDPRDTTTPAAMAASMNKLVLGDALRPAQRSQLAAWLKGNTTGDATIRAGAPTDWIVGDKT 240 
Y.ent_4           GMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTARPNDPRDTTTPAAMAASMNKLVLGDALRPAQRSQLAVWLKGNTTGDATIRAGAPTDWIVGDKT 240 
K.oxy             GMTLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPDLNSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKT 238 
C.kos             EMTLAELSAATLQYSDNTAMNKLLEHLGGTSNVTAFARSIGDTTFRLDRKEPDLNTAIPGDERDTTCPLAMAKSLHKLTLGDALAGAQRAQLVEWLKGNTTGGQSIRAGLPEGWVVGDKT 238 
                   **::**.**::******* * ::. ***   *. **:****  ***** ** **:* *.* **** * *** *:.**.**:**   **:**. ********. :**** * .* ***** 
166 234 130
Y.intem_702 GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDANPVPDVLALCQPKYFGRKF 284 
Y.ent_1A GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILS--- 291 
Y.ent_1B GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATQIILSQIS 294 
Y.ent_4 GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASVTKIILS--- 291 
K.oxy GAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL- 291 
C.kos GAGDYGTTNDIAVIWPEDRAPLILVTYFTQPQQDAKGRKDILAAAAKIVTEGL- 291 
                  *:***********:** . **::**.**** :::*:   ::**BMC Microbiology 2007, 7:25 http://www.biomedcentral.com/1471-2180/7/25
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(5'GAACATATCTCCTGCCTGCAAAT 3'), which amplified
a fragment of 827 bp [10]. Cycling conditions for blaA
included: initial denaturation at 95°C for 5 min followed
by 25 cycles each at 54°C for 30 sec, 72°C for 90 sec and
95°C for 30 sec, and a final extension at 72°C for 10 min.
For the blaB, cycling conditions for PCR were as described
by Stock et al. [10]. The PCR products were electro-
phoresed on 1% agarose gel in 1 × TAE (40 mM Tris ace-
tate, 1 mM EDTA, pH 8.0) buffer at a constant voltage of
80 V/cm.
PCR-Restriction Fragment Length Polymorphisms of bla 
genes
PCR-RFLP of blaA was carried out with NciI and HaeIII,
and that of blaB  with HaeIII and RsaI (New England
Biolabs Inc., Schwalbach, Germany) as per manufacturer's
Amino acid sequence alignment of AmpC β-lactamase (Bla-B) of Y. intermedia (strain C-702) and Y. frederiksenii (strain C-115)  and the nearest class C β-lactamase neighbors Figure 5
Amino acid sequence alignment of AmpC β-lactamase (Bla-B) of Y. intermedia (strain C-702) and Y. frederikse-
nii (strain C-115) and the nearest class C β-lactamase neighbors. Asterisks indicate identical amino acids. The con-
served motifs (64SXXK67, 150YSN152 and 314KTG316) typical of class C β-lactamases are underlined and in boldface. The 
GenBank accession numbers of the β-lactamases are as follows: Y.fred and Y.inter (ABD84040 and ABD84041, present 
study),Y.ent_1A (AAZ66331, Y. enterocolitica biovar 1A),Y.ent_2 (CAA44850, Y. enterocolitica, IP97 biovar 2), Y.ent_1B (Y. entero-
colitica 8081 biovar 1B),Y.berc (AAO21212, Y. bercovieri), Y.ald (AAO21211, Y. aldovae) and Y.ruck (AAM94804, Y. ruckeri).
64
Y.fred          QVAAIVNKTLKPLLEQQNIPGMAVAVFYDGKPQFFNYGVADIKA-GIPVTENTLFELGSVSKTFTGIAGEYAAQTGIMNLNDPVTEYAPELTGSQWQGVKMLHLATYTAGGLPLQLPDSV 119
Y.inter         QVAVIVNNTLKPLIKQQNIPGMAVAVFYDGKPQFFNYGVADIKA-DIPVTENTLFELGSVSKTFTGIAGEYAMQTGIMNLNDPVTEYAPELTGSQWQDVKMLHLATYTAGGLPLQLPDSV 119
Y.ent_1A        QVATIVNKTLTPLLEKQGIPGMAVAIFYDGKPQFFNYGMADIKT-GRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPELTGSQWKDVKMLHLATYTAGGLPLQLPDSV 119
Y.ent_2         QVATIVNNTLTPLLEKQGIPGMAVAVFYDGKPQFFNYGMADIKA-GRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPELTGSQWKDVKMLHLATYTAGGLPLQLPDSV 119
Y.ent_1B        QVATIVNNTLTPLLEKQDIPGMAVAVFYDGKPQFFNYGMADIKA-GRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPELTGSQWKDVKMLHLATYTAGGLPLQLPDSV 119
Y.berc          -----------------------------------NYGVADIKT-GRRVTENTLFELGSVSKTFTGVAGEYAVQTGMMNLNDPVTEYASELTGNQWKKVKMLHLATYTAGGLPLQLPDSV 84
Y.ald           ---------------------------YYFT-----WGMADEEQ-RRSVTEDTLFELGSVSKTFTGVLGGVAVAKGEIALNDPASKYWQALNIPQWSHITLLQLATYSAGGLPLQVPDAV 87
Y.ruck          ---------------------------ANLTTLPGEWLMSQANTGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQWEGISLLNLATYTAGGLPLQVPDNI 93
                                                    : ::: :     **::**************: *  *   * : *.**.::*   *.  **. :.:*:****:*******:** :
Y.fred          TDQKSLWQYYQQWQPQWAPGVMRNYSNASIGLFGALAVKKSQLTFENYMKEFVFQPLKLTHTFITVPESMQSNYAWGYKDGQPVRVTLGMLGEEAYGVKSTTKDMVRFM----------- 228
Y.inter         TDQKSLWQYYQQWQPQWAPGVMRNYSNASIGLFGALAVKRSQLTFEDYMKKYVFQPLKLTHTFITVPESMQSSYAWGYKDGQPVRVTLGMLGEEAYGVXTXXXDMVX------------- 226
Y.ent_1A        TDQKSLWQYYQQWQPQCAPGVMRNYSNASIGLFGALAVKRSQLTFENYIKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGMLGEEAYGVKSTSQDMVRFMQANMDPESLPA 239
Y.ent_2         TDQKSLWQYYQQWQPQWAPGVMRNYSNASIGLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGMLGEEAYGVKSTSQDMVRFMQANMDPESLPA 239
Y.ent_1B        TDQKALWQYYQQWQPQWAPGVMRNYSNASIGLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGMLGEEAYGVKSTSQDMVRFMQANMDPESLPA 239
Y.berc          TDQKSLWQYYQQWQPQWAPGVMRNYSNASIGLFGALAVKKSQLTFENYMMKNVFQPLKLKHTFITVPESMQSNYAWGYKDGQPVRVTLGMLGEEAYGVKSTSQDMVRFMQANMSPDSLPA 204
Y.ald           TDENELVNFYKQWQPQWSPGKTRQYANSSIGLFGVLAVKPSGLSFEQAMQQRVFTPLKLNHTFITVPDEVKNTYAWGYHEGKPVRVSPGMLDAESYEVKSSIKDMSRWMQANMNPQQVAV 207
Y.ruck          TDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGKLAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEAYGVKSSIKDMASWVRANMTPSEVKD 213
                **:. * ::*: **** :**  * *:*:***:** **** * ::**: : : ** **:* **:* :*:  :. *****::*:.*:*: ***. *:* * :   ** 
Y.fred          ----------------------------------------------------------------------------------------------------------------------
Y.inter         ----------------------------------------------------------------------------------------------------------------------
Y.ent_1A        G--------------------------------------------------------------------------------------------------------------------- 240
Y.ent_2         GNDKLKEAIIASQSRYFQAGDMFQGLGWEMYSWPINPQGVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEKVGIVMLANKNYPNPVRVQAAYDILQALR 357
Y.ent_1B        ANDKLKEAIIASQSRYFQAGDMFQGLGWEMYNWPINPQRVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEKVGIVMLANKNYPNPVRVQAAYDILQALR 357
Y.berc          ENDKLKRALIAA---------------------------------------------------------------------------------------------------------- 216
Y.ald KTLQQ----------------------------------------------------------------------------------------------------------------- 212
Y.ruck          ASLQKGILLAQSRYC------------------------------------------------------------------------------------------------------- 228
150
314
Table 3: Isoelectric points (pI) of β-lactamases (Bla-A and Bla-B) of Y. intermedia and Y. frederiksenii
Strains n pI
Bla-A Bla-B
Y. intermedia
Clinical 4 8.7 6.5, 6.8, 7.5
Non-clinicala 4 8.7 6.0, 6.8, 7.1, 7.8, 8.0
5.5, 6.0
6.8, 7.0
Y. frederiksenii
Clinical 6 8.7 6.0, 6.8, 8.0
Non-clinicalb 1 8.7 6.0, 6.8, 8.0
n: number of strains
aWastewater (2 strains) and pig throat (2 strains)
bIsolates from pig throatBMC Microbiology 2007, 7:25 http://www.biomedcentral.com/1471-2180/7/25
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instructions. The digestion mixture was incubated at 37°C
for 8 hours and resolved on 2% agarose gel in 1 × TBE
(Tris-Borate-EDTA). The gels were stained with ethidium
bromide (0.5 μg/ml) and photographed under UV illumi-
nation. Similarity amongst blaA and blaB was estimated by
cluster analysis of the restriction profiles of each gene
using Jaccard's similarity coefficient and a UPGMA
(Unweighted Pair Group Method with Arithmetic mean)
dendrogram was constructed separately for each gene
using Diversity Database software (Bio-Rad, USA).
Table 4: Biotypes, serotypes and sources of strains of Y. intermedia and Y. frederiksenii used in this study
S. No. Strain No.a Species Serotype Biotype Source Ref. Lab no.
1K / Y / 3 0 Y. intermedia O:40 4 Wastewater IP26142
2K / Y / 3 1 Y. intermedia O:40 4 Wastewater IP 26143
3 T/Y/33 Y. intermedia NAG 1 Wastewater IP 26259
4O / Y / 4 3 Y. intermedia O:40 4 Wastewater IP 26146
5 Ko/Y/57 Y. intermedia NAG 2 Wastewater IP 26306
6 R/Y/59 Y. intermedia O:40 4 Wastewater IP 26309
7O / Y / 6 0 Y. intermedia O:40 4 Wastewater IP 26 308
8 T/Y/65 Y. intermedia O:40 4 Wastewater IP 26318
9C - 5 9 4 Y. intermedia NAG 2 Clinical IP 27477
10 C-702 Y. intermedia 7,8-8 1 Clinical IP 72478
11 C-714 Y. intermedia NAG 1 Clinical IP 27479
12 C-752 Y. intermedia NAG 1 Clinical IP 27480
13 P-60 Y. intermedia -- P i g  t h r o a t -
14 P-114 Y. intermedia -- P i g  t h r o a t -
15 P-122 Y. intermedia -- P i g  t h r o a t -
16 P-144 Y. intermedia -- P i g  t h r o a t -
17 P-185 Y. intermedia -- P i g  t h r o a t -
18 P-225 Y. intermedia -- P i g  t h r o a t -
19 P-226 Y. intermedia -- P i g  t h r o a t -
20 P-262 Y. intermedia -- P i g  t h r o a t -
21 P-337 Y. intermedia -- P i g  t h r o a t -
22 P-360 Y. intermedia -- P i g  t h r o a t -
23 P-364 Y. intermedia -- P i g  t h r o a t -
24 P-366 Y. intermedia -- P i g  t h r o a t -
25 P-368 Y. intermedia -- P i g  t h r o a t -
26 P-369 Y. intermedia -- P i g  t h r o a t -
27 P-387 Y. intermedia -- P i g  t h r o a t -
28 P-396 Y. intermedia -- P i g  t h r o a t -
29 P-402 Y. intermedia -- P i g  t h r o a t -
30 P-430 Y. intermedia -- P i g  t h r o a t -
31 P-459 Y. intermedia -- P i g  t h r o a t -
32 P-460 Y. intermedia -- P i g  t h r o a t -
33 P-468 Y. intermedia -- P i g  t h r o a t -
34 P-474 Y. intermedia -- P i g  t h r o a t -
35 C-115 Y. frederiksenii NAG - Clinical IP27388
36 C-203 Y. frederiksenii 35 - Clinical IP27389
37 C-249 Y. frederiksenii 35 - Clinical IP27390
38 C-503 Y. frederiksenii 35 - Clinical IP27399
39 C-567 Y. frederiksenii 35 - Clinical IP27401
40 C-580 Y. frederiksenii 35 - Clinical IP27402
41 P-180 Y. frederiksenii -- P i g  t h r o a t -
42 P-236 Y. frederiksenii -- P i g  t h r o a t -
43 P-238 Y. frederiksenii -- P i g  t h r o a t -
44 P-240 Y. frederiksenii -- P i g  t h r o a t -
45 P-257 Y. frederiksenii -- P i g  t h r o a t -
46 P-259 Y. frederiksenii -- P i g  t h r o a t -
47 P-263 Y. frederiksenii -- P i g  t h r o a t -
48 P-270 Y. frederiksenii -- P i g  t h r o a t -
49 P-273 Y. frederiksenii -- P i g  t h r o a t -
a All strains were isolated from New Delhi, India
NAG: Non-agglutinable
IP: Yersinia National Reference Laboratory and WHO Collaborating Centre, Institut Pasteur, Paris (France)BMC Microbiology 2007, 7:25 http://www.biomedcentral.com/1471-2180/7/25
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Sequencing of blaA and blaB genes
The complete CDS of blaA gene (896 bp) of Y. intermedia
was amplified with primers A9-f and A10-r [20]. However,
CDS of blaA  of  Y. frederiksenii could not be amplified
using these primers. Thus, partial sequence of blaA (450
bp) of Y. frederiksenii was amplified using primers A7-f
and A8-r. The amplicons of blaA and blaB genes of repre-
sentative strains, each of Y. intermedia and Y. frederiksenii,
were purified using QIA Quick Gel Extraction Kit (Qiagen,
Germany) and sequenced by Big Dye Terminator Cycle
Sequencing Ready Reaction kit using ABI 310 Genetic
Analyzer (Applied Biosystems, Germany). The sequences
obtained were analyzed for homology with bla genes in
the existing GenBank database using Blastn [43]. The
deduced amino acid sequences of the proteins were
aligned with class A (for Bla-A) and class C (for Bla-B) β-
lactamases of other members of the family Enterobacte-
riaceae using ClustalW [44].
Molecular weight determinations of Bla-A and Bla-B 
enzymes
The molecular weights of the two β-lactamases were deter-
mined on SDS-PAGE. Crude cell lysate containing
enzymes was prepared by sonication of washed cell pellet
as described earlier [8]. For induction of enzyme Bla-B,
imipenem (final concentration 0.5 mg/l) was added dur-
ing the log phase of cell culture. The protein concentration
was estimated by Lowry's method [45]. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
was performed as described by Laemmli [46]. Briefly, 50
μg of protein was loaded on 12% resolving and 5% stack-
ing SDS-polyacrylamide gel (Mini Protean III, Bio-Rad,
USA) along with the medium range molecular weight pro-
tein marker (Bangalore Genei, India). The electrophoresis
was carried out at 80 V for 2 hours. For renaturation, the
gels were washed twice, for 45 min each, in renaturation
buffer (100 mM Tris HCl, pH 7.0 and 0.1% Triton-X-100)
under mild shaking. β-lactamase bands were visualized by
overlaying the gels with 0.5 mg/ml nitrocefin for 2 min.
The identity of the bands was further confirmed by spe-
cific inhibition with 40 μM clavulanic acid for Bla-A or 20
μM aztreonam for Bla-B.
Isoelectric focusing (IEF) of Bla-A and Bla-B enzymes
IEF of the crude enzyme extract (3 μg of protein) was per-
formed in 6% polyacrylamide gel containing 2%
ampholyte of pH 3 to 10 (Biolyte Ampholyte, Bio-Rad,
USA) using Mini IEF cell (Bio-Rad, USA) according to the
protocol specified by the manufacturer. A broad range IEF
standard with pI ranging from 4.45–9.6 (Bio-Rad, USA)
was used as pI marker. The β-lactamase bands were visu-
alized by overlaying the IEF gel with nitrocefin (0.5 mg/
ml). The identity of the bands was further confirmed by
specific inhibition with clavulanic acid and aztreonam as
described above.
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